Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-027666

Options or other derivatives

  • Director acquired 17,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lacey David L. Director 2022-05-05 Grant or award · Director Stock Option (right to buy) +17,500 17,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…